Multimodal imaging of foveoschisis and macular pseudohole associated with gyrate atrophy: a family report
- 53 Downloads
To report the results of multimodal imaging of a biochemically confirmed case of a family with gyrate atrophy (GA) associated with foveoschisis and macular pseudohole.
Two sisters presented to us with progressive bilateral decreased vision. The 26-year old sister had a best corrected visual acuity (BCVA) of 20/32 in the right eye (RE) and 20/100 in the left eye (LE). Dilated fundus examination revealed multiple bilateral chorioretinal atrophy areas in the midperipheral and peripheral retina. Fluorescein angiography did not show any leak in the macular area. Swept-source optical coherence tomography (SS-OCT) showed increased central macular thickness in both eyes with foveoschisis. Optical coherence tomography angiography (OCTA) showed petaloid non-reflective areas and some perifoveal microvascular alterations similar to telangiectasias in the deep capillary complex. The 30-year-old sister had a BCVA of 20/20 in the RE and 20/32 in the LE. SS-OCT was normal in the RE and demonstrated a macular pseudohole with a fine epiretinal membrane in the LE. The persistent retinal tissue at the base of the pseudohole was disorganised. Blood tests showed hyperornithinemia in the 2 cases. Based on these observations, the patients were diagnosed with gyrate atrophy of the choroid and retina and were treated with a pyridoxine supplement and an arginine-restricted diet.
Foveoschisis and macular pseudohole may be associated in GA, increasing the risk of rapid vision loss. OCTA is an interesting imaging tool that can help to better understand the pathophysiological mechanism of these macular involvements in GA.
KeywordsGyrate atrophy Foveoschisis Macular pseudohole Optical coherence tomography angiography
Best corrected visual acuity
Optical coherence tomography angiography
Swept-source optical coherence tomography
Gyrate atrophy (GA) of choroid and retina is a rare disease with recessive autosomal transmission . It is a metabolic disorder secondary to a congenital deficit in ornithine-δ-aminotransferase (OAT) causing hyperornithinemia. With an unknown mechanism, high levels of ornithine lead to a progressive chorioretinal atrophy [2, 3]. Patients with GA initially complain of night blindness and decreasing of peripheral vision typically in the second decade of life. Loss of central vision can occur in the fourth or the fifth decades.
Ophthalmological manifestations such as high myopia, marked astigmatism and early cataract formation are common . Macular involvements can be due to macular edema, choroidal neovascularisation, macular hole and unfrequently foveoschisis and epiretinal membrane . Two cases of foveoschisis and no case of macular pseudohole associated with GA, were reported [6, 7].
Here, we report the results of multimodal imaging of a biochemically confirmed case of a family with GA associated with foveoschisis and macular pseudohole. To our knowledge, this is the first report of GA imaged by optical coherence tomography angiography (OCTA) in the indexed peer-reviewed literature.
A 26 year-old and a 30-year-old Caucasian sisters presented to us with progressive bilateral decreased vision. There was no history of consanguineous marriage.
Swept-source optical coherence tomography (SS-OCT) showed increased central macular thickness at 398 μm in the RE and 355 μm in the LE. The presence of hyporeflective spaces extending from the outer plexiform layer to the inner plexiform layer, separated by multiple vertical bridges was suggestive of foveoschisis on both eyes (Fig. 1d,h).
OCTA showed petaloid non-reflective areas in the macular zone located predominantly inside of the deep capillary complex. Besides, there was evidence of some perifoveal microvascular alterations similar to telangiectasias located in the deep capillary plexus. Analysis of the choriocapillaris revealed a central dark grey area that was not associated with any evident aspect of a vascular alteration but could be attributed to a decreased signal due to a shadow effect (Fig. 2).
The visual field showed peripheral alterations and electrophysiology revealed reduced photopic responses with no recordable scotopic response.
Clinical aspect and multimodal imaging identified gyrate atrophy of the choroid and retina. Neurological examination was normal. Elevated plasma ornithine test confirmed the diagnosis (723 nmol/ml, with the normal range being 50 to 100 nmol/ml). An arginine-restricted diet and B6 vitamin supplementation (at dose of 300 mg/day) were prescribed. After a six-month follow-up, no retinal changes were observed.
The visual field and electrophysiology showed the same alterations as in the first case. No systemic manifestations were observed. Diagnosis of GA was confirmed by elevated plasma ornithine test.
The clinical examination of the parents was within normal.
Gyrate atrophy is a recessive autosomic disease affecting the OAT whose deficiency causes elevation of ornithine. The initial lesion is located on the pigmentary epithelium causing atrophy of the photoreceptors [8, 9]. In GA, by the age of 10, gradual blurred vision starts, becomes severe in the fourth or fifth decade. Rare and fine hair, mental retardation associated with diffuse cerebral atrophy and muscle damage, are the most described systemic manifestations .
Foveoschisis is a rare association with GA. To the best of our knowledge, this is the third report of this association [6, 7]. There were no previous reports of OCTA in GA. In case 1, the aspect of intra retinal cysts on SS-OCT and the absence of leak at macula at the late phase of FA was suggesting foveoschisis rather than cystoid macular edema.
Foveoschisis corresponds to the splitting of the inner retinal layers at the macula. In high myopia, foveoschisis is probably related to vitreoretinal interface factors, to a progressive ectasia of the sclera and a relative resistance to a stretch of the inner retinal layers and the retinal vessels [12, 13]. In X-linked retinoschisis, mutations in the RS1 gene cause a loss of functional retinoschisin which disturbs the cellular organization of the retina and structure of the photoreceptor-bipolar synapse . In GA, the pathogenesis of the foveoschisis is poorly understood. OAT activity is reported to be high in the retinal pigment epithelium which can explain that the initial lesion in GA is located on the pigmentary epithelium causing atrophy of the photoreceptors [8, 9]. So we can hypothesize that deficiency of essential products or toxicity of the accumulated excessive substrates, causing the chorioretinal degeneration in GA, may also disturb regulation of the fluid balance between the intracellular and extracellular environment. The extracellular fluid with cystic cavities causes disruption of the organized layers of the retina particularly within the photoreceptor and bipolar cell layers. However, pathogenesis of the foveoschisis in gyrate atrophy is probably multifactorial and can be related to vitreoretinal interface factors and to high myopia as in our patient . Nevertheless, high myopia is not always involved, as Tekin et al. described a case of foveoschisis associated with GA in low myopia .
The OCTA showed in our case some perifoveal microvascular alterations located in the deep capillary plexus which can be either a cause or a consequence of the foveoschisis. Starga et al. found similar macular lesions in cases of X-linked retinoschisis .
Further studies with OCTA imaging need to be performed to better define the pathogenesis of foveoschisis in GA.
Epiretinal membrane is also a rare association with GA . To the best of our knowledge, we report the first case of macular pseudohole imaged and published. Regarding its pathogenesis, several factors including aging, posterior vitreous detachment and genetic factors have been suggested to play a role in epiretinal membrane formation. In our case, the patient was young and macular pseudohole aspect was unusual as external retinal layers were disorganised and poorly individualized at the base of the pseudohole. This aspect must be distinguished from full-thickness macular hole, which has been also reported as a rare finding in GA .
In the treatment of GA, a low-protein diet, but sufficient for normal growth, is recommended. An arginine-free diet, if strictly obeyed, may decrease ornithine to normal levels but only 20% of patients are reported to tolerate this diet . Oral B6 supplementation is administered in order to decrease serum ornithine level with a clinical heterogeneity in responsiveness . Recently, Heller et al. reported for the first time an improvement of central macular edema with low protein intake and pyridoxine supplement . However, treatment effect on foveoschisis is still unknown. In our patient, a longer follow-up period is needed to evaluate the long-term treatment effect.
Association of GA with foveoschisis and macular pseudohole is rare but may increase the risk of rapid vision loss. The recent widespread clinical use of optical coherence tomography has better defined characteristics of macular abnormalities in GA. OCTA is an interesting imaging tool that can help to better understand the pathophysiological mechanism of macular involvements in GA.
No funding was obtained.
Availability of data and materials
All data supporting our findings are contained within the manuscript.
IZB performed the imaging of the patient, acquired the data and wrote the manuscript. IA examined the patient and made the diagnosis. RM collected the published data on gyrate atrophy, participated in patient care and in writing the manuscript. MB was responsible for obtaining consent and participated in writing the manuscript. IMB helped to establish the final imaging interpretation. KE critically revised the manuscript. RZ assisted in drafting its final version. All authors read and approved the final version of the manuscript.
Ethics approval and consent to participate
The Ethics Committee of the Charles Nicolle Hospital waived the need for formal approval in this case. Full consent for procedures described was obtained from both of the patients.
Consent for publication
Full verbal and written consent has been obtained from both of the patients for submission of this manuscript for publication.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
- 5.Inanc M, Tekin K, Teke MY. Bilateral choroidal neovascularization associated with gyrate atrophy managed with intravitreal bevacizumab. Int Ophthalmol. 2017; https://doi.org/10.1007/s10792-017-0579-2.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.